What's new

Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive

Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive

Mar 12, 2025 - 17:05
 0
Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive
Orphan designation: Ornithine phenylacetate Treatment of acute liver failure, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Adeno-associated viral vector serotype rh10 containing the h...

Next Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Related Posts

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:45 (CEST) to 9 May 2025, 15:45 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine,valsartan,hydrochlorothiazide, Date of authorisation: 03/11/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Recarbrio, imipenem,cilastatin,relebactam, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 7, 2025  0